Landscape Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-58,075
Closed -$4M 855
2024
Q2
$4M Buy
58,075
+5,027
+9% +$341K 0.34% 71
2024
Q1
$3.85M Buy
53,048
+45,695
+621% +$3.06M 0.34% 85
2023
Q4
$450K Sell
7,353
-7,986
-52% -$474K 0.04% 441
2023
Q3
$877K Buy
+15,339
New +$927K 0.12% 144
2016
Q1
Sell
-7,900
Closed -$407K 756
2015
Q4
$407K Buy
7,900
+2,056
+35% +$102K 0.05% 575
2015
Q3
$264K Sell
5,844
-3,856
-40% -$182K 0.04% 483
2015
Q2
$449K Sell
9,700
-492
-5% -$21.5K 0.08% 393
2015
Q1
$437K Buy
+10,192
New +$388K 0.12% 253

Other funds holding PBH

Landscape Capital Management's PBH Position: Q3 2024 in Review

Landscape Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q3 2024, closing a stake of 58,075 shares — an estimated $4M sold.

Landscape Capital Management first reported a position in PBH in Q1 2015 and held it in 8 quarters. The position peaked at $4M in Q2 2024. 328 funds tracked by Wall St. Rank hold PBH as of Q3 2024.

  • Landscape Capital Management reported no remaining Prestige Consumer Healthcare position as of Q3 2024 after selling out during the quarter.
  • Landscape Capital Management sold 58,075 Prestige Consumer Healthcare shares in Q3 2024, an estimated $4M.
  • Landscape Capital Management first reported a position in Prestige Consumer Healthcare in Q1 2015 and held it in 8 quarters.
  • Landscape Capital Management's Prestige Consumer Healthcare position peaked at $4M in Q2 2024.
  • 328 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2024.

Based on Landscape Capital Management's 13F filing for Q3 2024, filed 8 Nov 2024.